Arcus Biosciences (RCUS) EBT Margin (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Arcus Biosciences | 3.18 Bn | 2.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43,173.00 |
| Dec 31, 2025 | 19,802.00 |
| Mar 31, 2025 | -4,231.00 |
| Dec 31, 2024 | -16,603.00 |
| Sep 30, 2024 | 4,679.00 |
| Jun 30, 2024 | -23,570.00 |
| Mar 31, 2024 | 56,867.00 |
| Dec 31, 2023 | -35,580.00 |
| Sep 30, 2023 | 3,955.00 |
| Jun 30, 2023 | 5,683.00 |
| Mar 31, 2023 | -11,494.00 |
| Dec 31, 2022 | -9.00 |
| Sep 30, 2022 | 5,118.00 |
| Jun 30, 2022 | 12,407.00 |
| Mar 31, 2022 | -45,161.00 |
| Dec 31, 2021 | 90,357.00 |
| Sep 30, 2021 | -2,119.00 |
| Jun 30, 2021 | -3,569.00 |
| Mar 31, 2021 | -21,922.00 |
| Dec 31, 2020 | -55,089.00 |
| Sep 30, 2020 | 257,848.00 |
| Jun 30, 2020 | -98,977.00 |
| Mar 31, 2020 | -141,565.00 |
| Dec 31, 2019 | 108,662.00 |
| Sep 30, 2019 | 32,474.00 |
| Jun 30, 2019 | -59,651.00 |
| Mar 31, 2019 | -21,863.00 |
| Dec 31, 2018 | -51,882.00 |
| Sep 30, 2018 | 92,125.00 |
| Jun 30, 2018 | -15,064.00 |
| Mar 31, 2018 | 4,928.00 |
| Dec 31, 2017 | 1.31 Mn |